^
Association details:
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
Source:
Title:

IDENTIFICATION OF GENOMIC VARIANTS ASSOCIATED WITH LONG TERM MOLECULAR RESPONSE TO TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA

Published date:
05/14/2020
Excerpt:
Novel genes/variants associated exclusively with long-term CML responders to imatinib and absent in all control groups, namely PTPN22, TTN, PDLIM4, CACNA1B, CELF2, ANO5, MYO16, TP53, KCNJ12 and RAI1 genes...